About us

Alkalon A/S is an independent, privately owned Contract Research and Product Development company based in the Danish-Swedish life science cluster Medicon Valley.

The company has in-depth experience in formulation development of medicinal chewing gum and is working in partnership with Pharmaceutical companies on dosage form development projects and supply of finished products.

Alkalon's current focus is development of line extensions and continued commercialisation of a portfolio of new, improved generic nicotine gum formulations.

ALKALON FILES FOR EUROPEAN APPROVAL OF NICORONO NICOTINE GUM

Alkalon A/S has completed 2 years development work and now filed for regulatory approval of its new generic nicotine gum in a number of European countries anticipating commercial launch 2012.

COPENHAGEN, August 18, 2011. Alkalon today announced that it has filed for marketing approval of its generic nicotine gum for smoking cessation. Alkalon is seeking approval based on a clinical study that showed bioequivalence to the reference product NicoretteĀ® nicotine gum.

Syndicate content